December 5, 2017
BioPharma Credit, and BioPharma Credit Invesments lend $200 million to Lexicon
BioPharma Credit and BioPharma Credit Investments IV, a private fund that also invests in life sciences debt, have said they…
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
December 4, 2017
Arix Bioscience puts $8 million for a stake in Atox Bio, gets a place in Board of Directors
Arix Bioscience has led an oversubscribed $30 million Series F financing round for a clinical biotechnology company Atox Bio.
December 4, 2017
Idorsia welcomes $230 million milestone for Janssen’s agreement opt-in decision
Idorsia said Monday Janssen Biotech, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has exercised its option to enter…
December 4, 2017
Sanofi’s Toujeo neet main objective in head-to-head study versus insulin degludec
Sanofi’s Toujeo met the primary study objective in the first large head-to-head clinical trial, called BRIGHT study, comparing Toujeo with insulin…
December 4, 2017
XBiotech with potential breakthrough for treatment of HS with MABp1, study suggests
Texas-headquartered biosciences company XBiotech announced Monday the publication of data from its randomized phase 2 study in which it tested…
December 1, 2017
Faron welcomes new Chief Commercial Officer from AstraZeneca
Faron Pharmaceuticals has appointed Dr. Juhana Heinonen as Chief Commercial Officer to join the company in January 2018.
December 1, 2017
Destiny Pharma, China’s CMS Medical Venture ink deal for dealing with Destiny’s drug candidates in Asian region
Destiny Pharma said on Friday that its development and commercialisation collaboration agreement with CMS Medical Venture Investment Limited, a wholly…
December 1, 2017
Basila, Pfizer extend deal for several regions for Basilea’s Cresemba, adds China and 16 countries in Asia Pacific
Basilea Pharmaceutica International has amended its existing license agreement for Europe, Russia, Turkey and Israel with Pfizer Inc. for Basilea’s…
December 1, 2017
STA Pharmaceutical with visible growth in MAH programs in China
STA Pharmaceutical (STA) – a China-based global API and Drug Product CDMO – reports that it has seen a rapid…
November 30, 2017
ViiV kicks off third phase of HIV prevention study in women
ViiV Healthcare on Thursday announced the start of HPTN 084,a phase III study to evaluate long-acting cabotegravir for the prevention of…